MRDH bandage for surgery and trauma: Data summary and comparative review

Journal of Trauma - Injury, Infection and Critical Care

Volumn 71, Issue 2 SUPPL. 1, 2011, Pages

  Valeri, C Robert ^a   Vournakis, John N ^b  

^a Naval Blood Research Laboratory Inc   (United States)

^b Marine Polymer Technologies Inc   (United States)

Author keywords

Hemorrhage; Hemostasis; MRDH; PGlcNAc; Surgery; Trauma

Indexed keywords

AMINOCAPROIC ACID; APROTININ; DESMOPRESSIN; HEMOSTATIC AGENT; N ACETYLGLUCOSAMINE; NANOFIBER; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SILICON DIOXIDE; TRANEXAMIC ACID; POLY N ACETYL GLUCOSAMINE; POLY-N-ACETYL GLUCOSAMINE;

ACETYLATION; BANDAGES AND DRESSINGS; BLEEDING; BLOOD CLOTTING DISORDER; BLUNT TRAUMA; CELL ACTIVATION; CORONARY ARTERY BYPASS GRAFT; DIATOM; ELECTIVE SURGERY; ERYTHROCYTE; EXSANGUINATION; GUNSHOT INJURY; HEART SURGERY; HEART VALVE SURGERY; HEMAGGLUTINATION; HEMOSTASIS; HUMAN; INJURY; LIVER INJURY; LIVER SURGERY; MODIFIED RAPID DEPLOYMENT HEMOSTAT BANDAGE; NONHUMAN; ORTHOPEDIC SURGEON; PENETRATING TRAUMA; PRIORITY JOURNAL; REVIEW; STAB WOUND; SURGICAL INJURY; SURGICAL WOUND; SURVIVAL; THROMBOCYTE ACTIVATION; VASOCONSTRICTION; BANDAGE;

ACETYLGLUCOSAMINE; BANDAGES; HEMORRHAGE; HEMOSTASIS, SURGICAL; HUMANS; WOUNDS AND INJURIES;

EID: 84863708243     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31822555e9     Document Type: Review

References (51)

1. Champion HR, Bellamy RF, Roberts CP, Leppaniemi A. A profile of combat injury. J Trauma. 2003;54(5 suppl):S13-S19. (Pubitemid 36758844)
2. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a re-assessment. J Trauma. 1995;38:185-193.
3. Carr MEJ. Monitoring of hemostasis in combat trauma patients. Mil Med. 2004;169(suppl 12):11-15.
4. Schreiber MA. Coagulopathy in the trauma patient. Curr Opin Crit Care. 2005;11:590-597. (Pubitemid 41697333)
5. Fries D, Haas T, Salchner V, Lindner K, Innerhofer P. Management of coagulation after multiple trauma. Anaesthesist. 2005;54:137-144. (Pubitemid 40379360)
6. Armand R, Hess JR. Treating coagulopathy in trauma patients. Transfus Med Rev. 2003;17:223-231. (Pubitemid 36900330)
7. Jackson MR, Olson DW, Beckett WCJ, Olsen SB, Robertson FM. Abdominal vascular trauma: a review of 106 injuries. Am Surg. 1992; 58:622-626.
8. Lawson JH, Murphy MP. Challenges for providing effective hemostasis in surgery and trauma. Semin Hematol. 2004;41(suppl 1):55-64. (Pubitemid 38182718)
9. Ordog GJ, Wasserberger J, Balasubramanium S. Coagulation abnormalities in traumatic shock. Ann Emerg Med. 1985;14:650-655. (Pubitemid 15071772)
10. Hess JR, Zimrin AB. Massive blood transfusion for trauma. Curr Opin Hematol. 2005;12:488-492. (Pubitemid 41546481)
11. Ferrara A, MacArthur JD, Wright HK, Modlin IM, McMillen MA. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg. 1990;160:515-518. (Pubitemid 20375615)
12. Branas CC, Nance ML, Elliott MR, Richmond TS, Schwab CW. Urbanrural shifts in intentional firearm death: different causes, same results. Am J Public Health. 2004;94:1750-1755. (Pubitemid 39331765)
13. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma. 2003;55:39-44. (Pubitemid 36919234)
14. Wong K, Petchell J. Severe trauma caused by stabbing and firearms in metropolitan Sydney, New South Wales, Australia. ANZ J Surg. 2005; 75:225-230. (Pubitemid 40628330)
15. Persad IJ, Reddy RS, Saunders MA, Patel J. Gunshot injuries to the extremities: experience of a U.K. trauma centre. Injury. 2005;36:407-411. (Pubitemid 40248395)
16. Leissinger C, Becton D, Cornell C Jr, Cox Gill J. High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type I von Willebrand disease and symptomatic carriers of haemophilia A. Haemophilia. 2001;7:258-266. (Pubitemid 32471959)
17. Salzman EW, Weinstein MJ, Weintraub RM, et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. N Engl J Med. 1986;314:1402-1406. (Pubitemid 16114693)
18. Selin S, Tejani A. Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders. Issues Emerg Health Technol. 2006;82:1-4.
19. Martinowitz U, Zaarur M, Yaron BL, Blumenfeld A, Martonovits G. Treating traumatic bleeding in a combat setting: possible role of recombinant activated factor VII. Mil Med. 2004;169(suppl 12):16-18.
20. Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprtotinin during coronary artery bypass grafting and risk of death. N Engl J Med. 2008;358:771-783. (Pubitemid 351284455)
21. Shaw AD, Stafford-Smith M, White WD, et al. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med. 2008;358:784-793. (Pubitemid 351284456)
22. Koch CG, Li L, Sessler DI, Figueroa P, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:1229-1239. (Pubitemid 351439224)
23. Jewelewicz DD, Cohn SM, Crookes BA, Proctor KG. Modified rapid deployment hemostat bandage reduces blood loss and mortality in coagulopathic pigs with severe liver injury. J Trauma. 2003;55:275-280.
24. Connolly RJ. Application of the poly-N-acetyl glucosamine-derived rapid deployment hemostat trauma dressing in severe/lethal Swine hemorrhage trauma models. J Trauma. 2004;57:S26-S28. (Pubitemid 39079215)
25. Ward KR, Tiba MH, Holbert WH, et al. Comparison of a new hemostatic agent to current combat hemostatis agents in a swine model of lethal extremity arterial hemorrhage. J Trauma. 2007;63:276-284.
26. Arnaud F, Teranishi K, Tomori T, Carr W, McCarron R. Comparison of 10 hemostatic dressings in a groin puncture model in swine. J Vascular Surg. 2009;50:632-639.
27. Vournakis JN, Demcheva M, Whitson A, Guirca R, Pariser ER. Isolation, purification, and characterization of poly-N-acetyl glucosamine use as a hemostatic agent. J Trauma. 2004;57(suppl 1):S2-S6. (Pubitemid 39079210)
28. Fischer TH, Thatte HS, Nichols TC, Bender-Neal DE, Bellinger AD, Vournakis JN. Synergistic platelet integrin signaling and factor XII activation in poly-N-acetyl glucosamine fiber-mediated hemostasis. Biomaterials. 2005;26:5433-5443. (Pubitemid 40592133)
29. Fischer TH, Valeri CR, Smith CJ, et al. Non-classical processes in surface hemostasis: mechanisms for the poly-N-acetyl glucosamineinduced alteration of red blood cell morphology and surface prothrombogenicity. Biomed Mater. 2008;3:1-9.
30. Carr CJ, Vournakis JN, Demcheva M, Fischer TH. Differential effect of materials for surface hemostasis on red blood cell morphology. Microsc Res Tech. 2008;71:721-729.
31. Ikeda Y, Young LH, Vournakis JN, Lefer AM. Vascular effects of poly-N-acetyl glucosamine in isolated rat aortic rings. J Surg Res. 2002;102:215-220. (Pubitemid 34969470)
32. Favuzza J, Hechtman HB. Hemostasis in the absence of clotting factors. J Trauma. 2004;57(suppl 1):S42-S44. (Pubitemid 39079219)
33. Fischer TH, Connolly R, Thatte HS, Schwaitzberg SS. Comparison of structural and hemostatic properties of the poly-N-acetyl glucosamine Syvek Patch with products containing chitosan. Microsc Res Tech. 2004;63:168-174. (Pubitemid 38134251)
34. Thatte HS, Zagarins SE, Amiji M, Khuri SF. Poly-N-acetyl glucosamine- mediated red blood cell interactions. J Trauma. 2004;57(suppl 1):S7-S12. (Pubitemid 39079211)
35. Valeri CR, Srey R, Tilahun D, Ragno G. In vitro effects of poly-N-acetyl glucosamine on the activation of platelets in platelet-rich plasma with and without red blood cells. J Trauma. 2004;57(suppl 1):S22-S25. (Pubitemid 39079213)
36. Thatte HS, Zagarins S, Khuri SF, Fischer TH. Mechanisms of poly-Nacetyl glucosamine polymer-mediated hemostasis: platelet interactions. J Trauma. 2004;57(suppl 1):S13-S21. (Pubitemid 39079212)
37. Madhok A, Chowdhury D, Kholwadwala D. Use of SyvekPatch in children undergoing cardiac catheterization. Pediatr Cardiol Today. 2004;2:6-8.
38. Nader RG, Garcia JC, Drushal K, Pesek T. Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures. J Invasive Cardiol. 2002;14:305-307. (Pubitemid 34651237)
39. Najjar SF, Healey NA, Healey CM, et al. Evaluation of poly-N-acetyl glucosamine as a hemostatic agent in patients undergoing cardiac catheterization: a double-blind, randomized study. J Trauma. 2004;57(suppl 1):S38-S41. (Pubitemid 39079218)
40. Palmer BL, Gantt DS, Lawrence ME, Rajab MH, Dehmer GJ. Effectiveness and safety of manual hemostasis facilitated by the SyvekPatch with one hour of bedrest after coronary angiography using six-French catheters. Am J Cardiol. 2004;93:96-97. (Pubitemid 38022044)
41. Meyer KB. Control of post-dialysis bleeding in patients on chronic oral anticoagulation therapy. J Am Soc Nephrol. 1999;10:1A-867A.
42. Schwaitzberg SD, Chan MW, Cole DJ, et al. Comparison of poly-Nacetyl glucosamine with commercially available topical hemostats for achieving hemostasis in coagulopathic models of splenic hemorrhage. J Trauma. 2004;57(suppl 1):S29-S32. (Pubitemid 39079216)
43. King DR, Cohn SM, Proctor KG. Modified rapid deployment hemostat bandage terminates bleeding in coagulopathic patients with severe visceral injuries. J Trauma. 2004;57:756-759. (Pubitemid 39431196)
44. Vournakis JN, Demcheva M, Whitson AB, Finkielsztein S, Connolly RJ. The RDH bandage: hemostasis and survival in a lethal aortotomy hemorrhage model. J Surg Res. 2003;113:1-5. (Pubitemid 36999785)
45. Silverman T, Aebersold P, Landow L, Lindsey K. Regulatory perspectives on clinical trials for trauma, transfusion, and hemostasis. Transfusion. 2005;45(suppl 1):14S-21S. (Pubitemid 40931953)
46. Achneck HE, Sileshi B, Jamiolkowski, Albala DM, Shapiro ML, Lawson JH. A comprehensive review of topical hemostatic agents. Ann Surg. 2010;251:217-228.
47. Kheirabadi BS, Scherer MA, Estep JS, Dubick MA, Holcomb JB. Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine. J Trauma. 2009;67:450-460.
48. Clay JG, Grayson JK, Zierold D. Comparative testing of new hemostatic agents in a swine model of extremity arterial and venous hemorrhage. Mil Med. 2010;175:280-283.
49. Dubick MA, Kheirabadi B. New Technologies for Treating Severe Bleeding in Far-Forward Combat Areas. RTO-MP-HFM-182. NATO Research and Technology Organisation; 2010:21.
50. Kheirabadi B, Mace JE, Terrazas IB, et al. Safety evaluation of new hemostatic agents, smectite granules, and kaolin coated gauze in a vascular injury wound model in swine. J. Trauma. 2010;68:269-278.
51. Gerlach T, Grayson JK, Pichakron KO, et al. Preliminary study of the effects of smectite granules (WoundStat) on vascular repair and wound healing in a swine survival model. J Trauma. 2010;68:1-7.